These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31821586)

  • 21. Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
    Onozawa M; Hashino S; Takahata M; Fujisawa F; Kawamura T; Nakagawa M; Kahata K; Kondo T; Ota S; Tanaka J; Imamura M; Asaka M
    J Clin Microbiol; 2006 Dec; 44(12):4441-3. PubMed ID: 17035500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and case-fatality of varicella-zoster virus infection among pediatric cancer patients in developing countries.
    Ojha RP; Stallings-Smith S; Aviles-Robles MJ; Gomez S; Somarriba MM; Caniza MA
    Eur J Pediatr; 2016 Apr; 175(4):581-5. PubMed ID: 26608932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1.
    Inoue H; Motani-Saitoh H; Sakurada K; Ikegaya H; Yajima D; Hayakawa M; Sato Y; Otsuka K; Kobayashi K; Nagasawa S; Iwase H
    J Med Virol; 2010 Feb; 82(2):345-9. PubMed ID: 20029810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections.
    Grahn A; Bergström T; Runesson J; Studahl M
    J Infect; 2016 Sep; 73(3):254-60. PubMed ID: 27317379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Usefulness of Varicella-Zoster Virus Real-Time Polymerase Chain Reaction Analysis of DNA in Saliva and Plasma Specimens From Patients With Herpes Zoster.
    Park SY; Kim JY; Kim JA; Kwon JS; Kim SM; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect Dis; 2017 Dec; 217(1):51-57. PubMed ID: 29029120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation.
    Mawatari M; Isoda A; Miyazawa Y; Sawamura M; Matsumoto M
    Transpl Infect Dis; 2015 Aug; 17(4):544-50. PubMed ID: 26041667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.
    Miller C; Taylor-Salmon E; Emuren L; Landry M; Gershon A; Miller G
    BMC Infect Dis; 2023 Dec; 23(1):854. PubMed ID: 38057696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
    Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
    Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
    Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
    Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
    Mullane KM; Morrison VA; Camacho LH; Arvin A; McNeil SA; Durrand J; Campbell B; Su SC; Chan ISF; Parrino J; Kaplan SS; Popmihajlov Z; Annunziato PW;
    Lancet Infect Dis; 2019 Sep; 19(9):1001-1012. PubMed ID: 31399378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
    Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
    J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary varicella zoster infection compared to varicella vaccine reactivation associated meningitis in immunocompetent children.
    Amaral V; Shi JZ; Tsang AM; Chiu SS
    J Paediatr Child Health; 2021 Jan; 57(1):19-25. PubMed ID: 33295075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
    Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
    Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis.
    Düzgöl M; Özek G; Bayram N; Oymak Y; Kara A; Demirağ B; Karapınar TH; Ay Y; Vergin C; Devrim İ
    Turk J Haematol; 2016 Dec; 33(4):346-348. PubMed ID: 27751970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular diagnosis of zoster post varicella vaccination.
    Sauerbrei A; Uebe B; Wutzler P
    J Clin Virol; 2003 Jul; 27(2):190-9. PubMed ID: 12829041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella.
    Ishizaki Y; Tezuka J; Ohga S; Nomura A; Suga N; Kuromaru R; Kusuhara K; Mizuno Y; Kasuga N; Hara T
    J Infect; 2003 Aug; 47(2):133-8. PubMed ID: 12860147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.